Target intelligence / Profile preview

Ribosomal protein L24 pseudogene 6 (RPL24P6)

Target
RPL24P6
Molecular classification
Other (pseudogene; non-coding genomic element)
01

Overview

RPL24 pseudogene 6 (RPL24P6) is a processed pseudogene of the human ribosomal protein L24 gene (RPL24). Pseudogenes like RPL24P6 are formed via retrotransposition of mRNA and lack protein-coding capability due to disablements such as premature stop codons, frameshifts, and absence of regulatory sequences. The human genome contains thousands of ribosomal protein pseudogenes, most of which are non-functional remnants and do not contribute to ribosome biogenesis or cellular activities. RPL24P6 should not be confused with RPL24, which encodes a component of the large 60S ribosomal subunit important for protein synthesis. RPL24P6's role is strictly genomic; it has no demonstrated biological function, does not serve as a biomarker or drug target, and is not directly associated with human diseases. Key clarification: - RPL24P6 is a pseudogene, not a protein or receptor, and is not considered a molecular target for therapy or research, except in studies of genome structure and evolution. - The parent functional gene is RPL24 ("60S ribosomal protein L24"); if you intended the functional protein, refer to that name for molecular functions or disease involvement.

Other names
RPL24P6RPL24_3_450ribosomal protein L24 pseudogene 6

Beyond the preview

Go deeper on Ribosomal protein L24 pseudogene 6 (RPL24P6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L24 pseudogene 6 (RPL24P6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call